Surgical or Medical Treatment

• Status: Recruiting
• Trial end date: 2024-08-30
• Target enrollment: 0
• Participant gender: All

Summary

This study will test the hypothesis that metabolic bariatric surgery will be more effective at providing durable glycemic control and reduce co-morbidities than intensive medical therapy in youth with type 2 diabetes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Hospital Medical Center, Cincinnati
• Collaborator: Children's Hospital Colorado

Criteria

Inclusion Criteria:

• Age 13-19.9 years of age at time of consent

• Type 2 diabetes by the American Diabetes Association criteria

• Negative diabetes-associated antibodies

• BMI greater than or equal to 35

• Willingness to take oral medications and/or diabetes subcutaneous medications as medically indicated

Exclusion Criteria:

• Known type 1 diabetes of maturity onset diabetes on the young (MODY) or secondary diabetes

• Chronic kidney or liver disease (except NAFLD or DKD)

• Pregnancy or breast-feeding

• Genetic cause of obesity or hypothalamic obesity

• Prior bariatric surgery

• History of malignancy

• Current participating in another clinical trial affecting study outcomes